Anixa Biosciences Inc (ANIX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US03528H1095
Anixa Biosciences Inc financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -11.70 m USD |
| EBIT | -11.03 m USD |
| Net income | -10.93 m USD |
| Diluted EPS – continuing operations | -0.34 USD |
Full history since 1985, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Anixa Biosciences Inc
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
More stocks
- Unitron Tech Co Ltd (142210.KQ)
- Madup Inc. (0039P0.KQ)
- Ablerex Electronics Co Ltd (3628.TWO)
- Lotte Himart (071840.KS)
- RESOURCES CONNECTION, INC. (RGP)
- Jerash Holdings (US), Inc. (JRSH)
- Technos S.A (TECN3.SA)
- Capstone Energy Plus, Inc. (CEPL)
- AleAnna, Inc. (ANNA)
- Fulin Plastic Industry Cayman Holding Co Ltd (1341.TW)
- Western Energy Services Corp. (WRG.TO)
- Koryo Credit Information Co. Ltd (049720.KQ)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.